Invesco Ltd. Purchases 5,234 Shares of Proto Labs, Inc. $PRLB

Key Points

• Invesco Ltd. increased its stake in Proto Labs, Inc. by 5.4% during the 1st quarter, bringing its total ownership to 101,970 shares valued at about $3.57 million.
• Several analysts have upgraded their ratings for Proto Labs, with Craig Hallum transitioning from "hold" to "buy" and setting a target price of $54.00.
• Shares of Proto Labs opened at $50.71 and reported $0.41 earnings per share, surpassing analyst expectations, with revenue for the quarter climbing by 7.6% year-over-year.

Invesco Ltd. boosted its stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 5.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 101,970 shares of the industrial products company's stock after buying an additional 5,234 shares during the period. Invesco Ltd. owned approximately 0.43% of Proto Labs worth $3,573,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in PRLB. GAMMA Investing LLC boosted its holdings in Proto Labs by 249.4% in the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 661 shares in the last quarter. Quarry LP lifted its holdings in Proto Labs by 175.7% in the fourth quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock valued at $62,000 after acquiring an additional 1,010 shares during the period. CWM LLC increased its position in shares of Proto Labs by 50.4% in the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after buying an additional 617 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Proto Labs by 14.1% in the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after buying an additional 267 shares in the last quarter. Finally, Lazard Asset Management LLC raised its holdings in shares of Proto Labs by 182.3% in the fourth quarter. Lazard Asset Management LLC now owns 5,875 shares of the industrial products company's stock worth $228,000 after acquiring an additional 3,794 shares during the last quarter. 84.54% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PRLB shares. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price for the company in a report on Friday, August 1st. Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Finally, Cantor Fitzgerald upped their price objective on Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $52.50.

Insider Transactions at Proto Labs

In other Proto Labs news, CEO Suresh Krishna acquired 1,725 shares of the business's stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the transaction, the chief executive officer owned 18,021 shares in the company, valued at $784,093.71. This trade represents a 10.59% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.20% of the company's stock.

Proto Labs Stock Performance

Shares of NYSE:PRLB traded down $1.08 during trading on Monday, hitting $49.69. 207,182 shares of the stock were exchanged, compared to its average volume of 185,243. The company's fifty day simple moving average is $43.29 and its 200-day simple moving average is $39.47. The company has a market capitalization of $1.19 billion, a price-to-earnings ratio of 82.81 and a beta of 1.27. Proto Labs, Inc. has a 1-year low of $26.34 and a 1-year high of $51.09.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.33 by $0.08. The business had revenue of $135.06 million for the quarter, compared to analyst estimates of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.Proto Labs's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.38 EPS. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, research analysts forecast that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.